Translational Mini-Review Series on Vaccines: Development and evaluation of improved vaccines against tuberculosis
- 15 January 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 147 (3) , 401-411
- https://doi.org/10.1111/j.1365-2249.2006.03306.x
Abstract
Summary: Tuberculosis (TB) continues to be a major global health disaster, despite the widespread use of BCG and effective drug therapies. The development of an efficacious new TB vaccine would be an important component of disease control in the future. Many approaches are being utilised to enhance understanding of the requirements of a successful vaccine. Numerous vaccines are being designed and assessed in a series of animal models, with a few progressing to clinical trials. Here, the steps involved in the development and evaluation of TB vaccines will be discussed, including description of the most frequently used animal models and the processes involved in advancing vaccines to phase III trials.Keywords
This publication has 111 references indexed in Scilit:
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006
- Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trialThe Lancet, 2005
- The global tuberculosis situation and the new control strategy of the World Health OrganizationPublished by Elsevier ,2004
- Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisNature Medicine, 2003
- Use of the bovine model of tuberculosis for the development of improved vaccines and diagnosticsTuberculosis, 2003
- Immunological Basis for Reactivation of Tuberculosis in MiceInfection and Immunity, 2001
- Restraining mycobacteria: Role of granulomas in mycobacterial infectionsImmunology & Cell Biology, 2000
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor DeficiencyScience, 1998
- Immune Response to Recombinant Mycobacterial Proteins in Patients with Tuberculosis Infection and DiseaseThe Journal of Infectious Diseases, 1996